undamentalytics Newsletter
Sign in

Dariohealth Corp. revenue

Dariohealth Corp.'s revenue was $22.4m in fiscal 2025, down 17.3% on the year before. Since fiscal 2014 ($51,000) it has grown at a compound 73.8% a year. Over the last twelve months it was $21.0m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue00135788212820272221
Growth on the year before——+>999%+240.6%+84.4%+43.0%+2.2%+0.2%+170.8%+34.8%−26.4%+32.9%−17.3%—
Gross profit0−3−1−112334106131312
Gross margin———−29.6%25.4%23.9%34.4%33.2%19.3%34.9%29.4%49.1%56.6%58.2%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Services $14.9M 66.8% ▼ 26.1%
Hardware and Consumable Products $7.4M 33.2% ▲ 8.6%

From Dariohealth Corp.'s 10-K filed March 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Dariohealth Corp. $21.0m -22.6% -7.6%
Healthcare Triangle, Inc. $25.7m 116.4% -14.9%
Mobile-health Network Solutions $7.7m 1.2% —
Sophia Genetics SA $77.3m 18.6% —
Optimizerx Corp $98.7m -5.8% 17.0%
Carecloud, Inc. $129m 15.1% 0.8%

Compare with peers

Head to head: DRIO vs HCTIDRIO vs MNDRDRIO vs SOPH

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Dariohealth Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Dariohealth Corp.